Rewriting the 'Points to consider': The ethical impact of guidance document language

Human Gene Therapy

Volumn 10, Issue 1, 1999, Pages 133-139

  King, Nancy M P ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EXPECTATION; GENE THERAPY; GENE TRANSFER; LITERATURE; MEDICAL RESEARCH; NOMENCLATURE; PRACTICE GUIDELINE;

ETHICS, MEDICAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; GUIDELINES; HUMANS; INFORMED CONSENT; NATIONAL INSTITUTES OF HEALTH (U.S.); RESEARCH; UNITED STATES;

EID: 0032908728     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950019264     Document Type: Article

References (23)

1. ADVISORY COMMITTEE ON HUMAN RADIATION EXPERIMENTS. (1996). The Human Radiation Experiments. (Oxford University Press, NY).
2. ANNAS, G.J. (1989). Faith (healing), hope and charity at the FDA. The politics of AIDS drug trials. Villanova Law Rev. 34, 771.
3. ANNAS, G.J. (1996). Questing for grails: Duplicity, betrayal and self-deception in postmodern medical research. J. Contemporary Health Law Policy. 12, 297-324.
4. APPELBAUM, P. (1996). Commentary: Examining the ethics of human subjects research. Kennedy Inst. Ethics J. 6, 283-287.
5. BOUCHER, R., and KNOWLES, M. (1994). Gene therapy for cystic fibrosis using E1-deleted adenovirus: A phase I trial in the nasal cavity. Hum. Gene Ther. 5, 615, 636-639.
6. CHURCHILL, L.R., COLLINS, M.L., KING, N.M.P., PEMBERTON, S.G., and WAILOO, K.A. (1998). Genetic research as therapy: Implications of "gene therapy" for informed consent. J. Law Med. Ethics 26, 38-47.
7. CODE OF FEDERAL REGULATIONS. (1991). Federal policy for the protection of human subjects. (Title 45 CFR Part 46).
8. CULVER, K.W. (1996). Gene Therapy: A Primer for Physicians. (Mary Ann Liebert, Inc., Larchmont, NY). p. xvii.
9. GENERAL ACCOUNTING OFFICE. (March 8, 1996). Scientific Research: Continued Vigilance Critical to Protecting Human Subjects. (GAO/HEHS-96-72).
10. GOLDNER, J. (1993). An overview of legal controls on human experimentation and the regulatory implications of taking Professor Katz seriously. St. Louis U. Law J. 38, 63-134.
11. KING, N.M.P. (1995). Experimental treatment: Oxymoron or aspiration? Hastings Center Rep. 25(4), 6-15.
12. LEVINE, R. (1988). Ethics and Regulation of Clinical Research, 2nd Ed. (Yale University Press, New Haven, CT) p. 8.
13. LYSAUGHT, M.T. (1998). Commentary: Reconstruing genetic research as research. J. Law Med. Ethics 26, 48-54.
14. MARINER, W. (1989). Equitable access to biomedical advances: Getting beyond the rights impasse. Connecticut Law Rev. 21, 571-603.
15. NATIONAL COMMISSION FOR THE PROTECTION OF HUMAN SUBJECTS OF BIOMEDICAL AND BEHAVIORAL RESEARCH. (1978) The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. DHEW Pub. No. (OS) 78-0012. (U.S. Government Printing Office, Washington, D.C.).
16. NATIONAL INSTITUTES OF HEALTH. (1997). Recombinant DNA research: Actions under the guidelines; notice. Federal Register 62, 59031-59046 (October 31, 1997).
17. NATIONAL INSTITUTES OF HEALTH. (1998). Guidelines for Research Involving Recombinant DNA Molecules, Appendix M, Points to Consider in the Design and Submission of Protocols for the Transfer of Recombinant DNA Molecules into One or More Human Subjects 〈http://www.nih.gov/od/orda/apndxm.htm〉. Published in the Federal Register, 59 FR 34496, as amended, 59 FR 40170, 60 FR 20726, 61 FR 1482, 61 FR 10004, 62 FR 4782.
18. OFFICE OF THE INSPECTOR GENERAL, DHHS (June 1998). Institutional Review Boards: A Time for Reform. OEI-01-97-00190-93 〈http://www.dhhs.gov/progorg/oei〉.
19. ORKIN, S.H., and MOTULSKY, A.G. (December 7, 1995). Report and Recommendations of the Panel to Assess the N.I.H. Investment in Research on Gene Therapy: National Institutes of Health Ad Hoc Committee Report 〈http://www.nih.gov/od/orda/panelrep/html〉.
20. PRESIDENT'S COMMISSION FOR THE STUDY OF ETHICAL PROBLEMS IN MEDICINE AND BIOMEDICAL AND BEHAVIORAL RESEARCH. (1982). Splicing Life. (U.S. Government Printing Office, Washington, D.C.).
21. ROSS, G., ERICKSON, R., KNORR, D., MOTULSKY, A.G., PARKMAN, R., SAMULSKI, J., STRAUS, S.E., and SMITH, B.R. (1996). Gene therapy in the United States: A five-year status report. Hum. Gene Ther. 7, 1781-1790.
22. WALTERS, L., with PALMER, J.G. (1997). The Ethics of Human Gene Therapy. (Oxford University Press, NY), p. 149.
23. WORLD MEDICAL ASSEMBLY. (1964). Declaration of Helsinki: Recommendations guiding doctors in biomedical research involving human subjects. N. Engl. J. Med. 271, 473.